just some older misc news bits, cool >>>>>>>>>>>>>>
-ViaDerma, Inc. produces TetraStem, a wound care drug that can also treats diabetic foot sores, acne and fight Methicillin-resistant Staphylococcus aureus (MRSA) infections
-LOS ANGELES, Calif. (May 12, 2016) -- ViaDerma, a Los Angeles-based pharmaceutical firm signed a deal with Coast to Coast Podiatry of Reseda to license its products. According to Dr. Chris Otiko, CEO of ViaDerma, the partnership will be beneficial to both companies. “ViaDerma will get our new products in front of patients who need them. And Coast to Coast will have
cutting-edge medicine to help their patients in recovery,” he said.
-May 12, 2016 ViaDerma announces testing on non surgical face-life kit
-May 13, 2016 Testing on toenail antifungal solution begins
-Nov 14, 2016 ViaDerma, Inc. Enters the (MMJ) or Medical Marijuana industry with a Patent Pending CBD Delivery System as California Votes for Expanded Uses of Cannabis. The Treatment Success of ViaDerma's Proprietary Delivery System for Several Diseases by the Efficient and Effective Transdermal Delivery of CBD's & THC to the Localized Treatment Area & into the Blood Stream
-Nov 30, 2016 ViaDerma, Inc. Clinical Studies Abroad in Europe, the Middle East and Asia Show Promising Results & Leads to Private Label Discussions
Clinical Tests Show Dramatic Success of ViaDerma's Proprietary Delivery System Combined with FDA Approved Drugs for Wound Healing with Localized Wound Treatment -- This Leads to Early-Stage discussions with two Pharmaceutical Companies to Private Label Viabecline for Distribution in Europe, Asia, the Middle East, and North Africa
